Study To Assess Changes In The Number Of Nerves In The Skin At The Site Where Where Tanezumab Is Injected

Completed · Phase 1 · Has a placebo group

Conditions studied: Osteoarthritis Pain, Chronic Low Back Pain, Pain Due to Interstitial Cystitis

In brief

Subcutaneous administration of tanezumab can result in changes in the number of nerves around the injection site in the thigh.

Key facts

Study ID

NCT01030640

Run by

Pfizer

People needed

28

Starts

2009-12-01

Expected to finish

2010-09-01

Last updated by the study team

2011-04-26

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy subjects only
• Female subjects can not be pregnant or be nursing.
• Females and males need to use two types of birth control methods during the length of the study and one of the two methods needs to be a barrier method.
• Subjects who are willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures.

You may not qualify if…

• Subject can not have any chronic or acute medical condition or have had any chronic illness in the past
• Can not have any problematic skin condition.
• Females can not have more than 7 alcoholic drinks per week and males can not have more than 14 alcoholic drinks per week

Where it is running

• Pfizer Investigational Site — Overland Park, Kansas, United States
• Pfizer Investigational Site — Overland Park, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.